Akamai Technologies Inc (AKAM) (Q3 2026) Earnings Call Highlights: $14 Billion CIS

Akamai Technologies (AKAM) reported Q3 2026 earnings, highlighting an $11.6B deal with Anthropic, bringing total CIS commitments to over $14B. CIS revenue is expected to double in 2027, driving 17-22% total revenue growth. However, supply chain delays pushed $30M in revenue to 2027, and Q4 EPS guidance is below year-ago levels. Margins are under pressure due to colocation costs, with improvements expected in 2028. Security revenue grew 9% YoY, while delivery revenue declined 3%.

Original reporting
Published Nov 6, 2026, 7:23 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 6, 2026, 7:34 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Akamai Technologies Inc (AKAM) (Q3 2026) Earnings Call Highlights: $14 Billion CIS — source image
Decision brief

The 30-second read

$AKAMNeutralHigh
01

Why it matters

The new contract and raised revenue outlook could lift AKAM, but margin guidance introduces downside risk.

02

Market read

First‑report earnings call with material guidance and a multi‑billion AI contract; actionable for traders.

03

What to watch

Potential delays in data‑center build‑out and the impact of colocation cost escalators on cash flow.

Relevance 8/10Novelty 8/10Timing: post‑earnings today

Background

Akamai's Q3 2026 earnings call provided fresh guidance and disclosed a major AI compute contract with Anthropic.

Company-level read

Ticker impact

$AKAMNeutralHigh confidence
Context

Akamai disclosed a new $11.6B seven‑year CIS contract with Anthropic and raised 2027 CIS revenue guidance to $1.1‑$1.3B, plus Q4 EPS guidance of $1.50‑$1.70.

Expected impact

likely modest upside as investors price in the new contract, tempered by margin‑pressure concerns

Evidence & confidence

Guidance and a multi‑billion deal are primary disclosures; the market will likely bid the stock higher, but margin guidance tempers enthusiasm.

Market effects

Strengthens the cloud‑infrastructure and edge‑computing sector, highlighting demand for CIS services.

Positive for U.S. tech stocks focused on AI compute services.

Signals growing enterprise spend on AI compute, relevant for global AI infrastructure providers.

Counterpoint

Margin pressure and high CapEx could erode near‑term earnings, suggesting caution.

Key entities

  • Akamai Technologies Inc.

    US‑listed provider of edge computing and security services (NASDAQ:AKAM).

  • Anthropic

    AI startup securing a $11.6B seven‑year compute infrastructure deal with Akamai.

Related articles

$AKAMHighAI 8/10

Why is Akamai Technologies stock rallying today?

Akamai Technologies (AKAM) stock rose 5.0% in pre-market trading after reporting Q3 2026 earnings beat and a $11.6B cloud deal with Anthropic. CEO Tom Leighton forecasted 17–22% revenue growth in 2027 and $7B+ in 2028. Analysts had mixed reactions to Q4 guidance, with some cutting price targets due to supply constraints.

$AKAMHigh

UBS lowers Akamai stock price target on compute supply constraints

UBS reduced its price target for Akamai Technologies (NASDAQ:AKAM) to $90 from $100, citing compute supply constraints and mixed guidance. The stock trades at $77.84, near its 52-week low. Akamai's Q3 results met expectations, but Q4 guidance was mixed. UBS maintained a Neutral rating, noting concerns over near-term profitability and AI economy exposure. Akamai expects 25% revenue CAGR from fiscal 2026-2028. Guggenheim reiterated a Buy rating with a $225 target.

$AKAMHigh

Guggenheim reiterates Akamai stock rating citing AI deal economics

Guggenheim reiterated a Buy rating and $225 price target for Akamai (AKAM) after its earnings and guidance. The stock is down 16% in a week. Akamai's Q3 2026 earnings beat estimates, but its stock fell. The company's 2027 and 2028 guidance exceeded consensus, driven by a large AI deal with Anthropic. The deal has a $11.6B total value and $2.2B annual recurring revenue, with expected 30% non-GAAP operating margins.